Hypertension among most common features of emergency hospital visit during COVID-19 lockdowns, says study
The researchers behind this study reveal that the compulsory lockdown period was linked to a 37 percent increase in the odds of having hypertension in patients visiting the hospital’s emergency department
Delhi hikes mask fines to Rs 2,000 as cases soar; Serum Institute CEO hopes for effective vaccine by May-June
Delhi has taken various measures this week to rein in the rising number of cases including flying in paramedical personnel, increasing the hospital beds, raising the fine for not wearing masks and imposing a tab on wedding guests
COVID-19 treatment: Melatonin hormone that regulates sleep-wake cycle may prove effective in managing infection
Clinical registries from Cleveland Clinic also showed that regular use of melatonin was associated with a 30 percent lesser chance of testing positive for COVID-19 even after adjusting for age, smoking history, race, and the presence of comorbidities
Experts suggest that it may be a combination of the infection as well as the inflammation caused due to the virus in the ear that may be responsible for sensorineural hearing loss in COVID-19 patients
Age does not increase susceptibility to COVID-19, but likely to effect severity of infection, study suggests
A group of scientists claim that age may not be linked to COVID-19 susceptibility after all. However, the claim that older people may be at risk of developing severe disease and dying of COVID-19 if they get it still holds true.
Shorter time between symptom onset and hospitalisation associated with severe COVID-19 symptoms, finds study
The results of the study showed that after ECMO, the in-hospital death rate after 90 days was only 37.4 percent, whereas it was 46 percent in the group that received conventional treatment
The IMA sought an "inclusive national solatium" for the families of such doctors, and added that a family member should be provided a government job as per their qualification
Coronavirus Updates: NEET, JEE to be held as per schedule, says NTA amid demands for postponing exams
Coronavirus Updates: While the Joint Entrance Examination (Main) is scheduled from 1-6 September, the National Eligibility cum Entrance Test (NEET-UG) is planned on 13 September
Coronavirus Updates: A tally based on figures provided by states and Union Territories on Saturday showed the countrywide caseload at 30,37,657 and toll at 56,762
A test against bacterial pneumonia resulted in zero deaths in a group who got photodynamic therapy while 60% of the control group participants died
A blood test can tell which COVID-19 patient should get steroid treatment and who would react adversely to it
The study suggested steroid therapy may benefit patients with severe inflammation, but may negatively impact those with less severe inflammation
WHO chief says there is no return to normalcy in the future, too many countries are heading in the wrong direction with Coronavirus
The WHO said that government and individual responses should depend on local virus conditions - namely, whether there is community spread or no.
The apex court directed the Centre to consider framing guidelines on the issue of cost of treatment for COVID-19.
China allows limited use of COVID-19 vaccine CanSino for their military after clinical trials shows its effectiveness
The vaccine has been approved for a period of one year after clinical trials proved it was safe and showed some efficacy.
Ramdev and the Coronil claim: Patanjali treading on thin legal ice, but enforcement gaps might let yoga guru get away with COVID 'drug'
Patanjali Ayurved is treading on thin legal ice with regard to the true effect of the drug compared to what is claimed. Considering the widespread adverse impact that could result from reliance upon an ineffective drug during a deadly pandemic, the question also arises as to whether the usual standard of approval of new drugs is sufficient for the present situation or whether a different standard has to be adopted despite the urgent need for a remedy.
Glenmark claims that favipiravir showed improvement of up to 88 percent in mild to moderate COVID-19 cases.
Hetero gets DCGI nod to launch anti-viral drug Remdesivir under brand name Covifor for COVID-19 treatment
The drug has been granted approval by DCGI for the treatment of suspected or laboratory-confirmed cases of COVID-19 in adults and children, hospitalised with severe symptoms of the disease, the company said.
Steroids like dexamethasone can suppress immune systems, and many physicians are using them on a case-by-case basis.
Developing a treatment or vaccine for severe COVID-19 is currently the world's top public health priority.
US COVID-19 survivor gets whopping USD 1.1 million hospital bill; man was admitted for 62 days at medical facility in Washington
Michael Flor battled with coronavirus for 62 days at Swedish Issaquah, making him the longest coronavirus patient at the hospital.